文献速递系统性红斑狼疮其他结缔组织病

瑞典系统性红斑狼疮患者妊娠早期暴露于羟氯喹与先兆子痫及早产发生率:一项全国性人群队列研究

Exposure to hydroxychloroquine in early pregnancy and incidence of pre-eclampsia and pre-term delivery in patients with systemic lupus erythematosus in Sweden: a nationwide population-based cohort study.
PubMed 文献 · Lancet Rheumatol · 2025-06-11

该全国性人群队列研究纳入2007年1月1日至2022年12月31日瑞典685例系统性红斑狼疮(SLE)患者的959次单胎妊娠,比较妊娠早期羟氯喹暴露与未暴露者先兆子痫和早产风险。调整混杂后,羟氯喹暴露与先兆子痫风险降低相关(RR 0.49,95%CI 0.31-0.79),但与早产关联不明确(RR 0.95,95%CI 0.67-1.34)。

要点

  • 妊娠早期羟氯喹暴露与SLE孕妇先兆子痫风险降低相关(RR 0.49,95%CI 0.31-0.79)。
  • 羟氯喹暴露与早产的关联不明确(RR 0.95,95%CI 0.67-1.34)。
  • 经产妇中先兆子痫风险降低更明显(RR 0.44,95%CI 0.22-0.89),初产妇未达统计学显著(RR 0.59,95%CI 0.33-1.08)。

核心结论

  • 在SLE妊娠女性中,妊娠早期羟氯喹暴露与先兆子痫风险降低相关,但与早产的关联不明确。

研究设计与样本

  • 全国性人群队列研究,纳入2007年1月1日至2022年12月31日瑞典二级或三级医疗中心诊断的SLE女性所有单胎妊娠(活产和死产)。
  • 共纳入685例SLE女性的959次单胎妊娠;初产妇404次(42%),经产妇555次(58%)。
  • 羟氯喹暴露定义为孕前3个月至妊娠早期结束期间至少两次配药。
  • 采用逆概率治疗加权调整已测量混杂因素(如母亲吸烟、BMI、生殖特征、孕前高血压、糖皮质激素使用),并用改良Poisson模型估计风险比和95%CI。

主要发现

  • 初产妇组先兆子痫:羟氯喹暴露172次中19次(11%),未暴露232次中30次(13%)。
  • 经产妇组先兆子痫:羟氯喹暴露222次中12次(5%),未暴露333次中20次(6%)。
  • 初产妇组早产:羟氯喹暴露172次中33次(19%),未暴露232次中34次(15%)。
  • 经产妇组早产:羟氯喹暴露222次中26次(12%),未暴露333次中41次(12%)。
  • 调整后先兆子痫风险比:总体0.49(95%CI 0.31-0.79),初产妇0.59(95%CI 0.33-1.08),经产妇0.44(95%CI 0.22-0.89)。

关键数值与推荐

  • 先兆子痫诊断标准:妊娠20+0周至产后6周内诊断。
  • 早产定义:妊娠37+0周前分娩。
  • 羟氯喹暴露定义:孕前3个月至妊娠早期结束期间至少两次配药。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pregnant women with systemic lupus erythematosus (SLE) have elevated risks of pre-eclampsia and pre-term delivery. Hydroxychloroquine, the mainstay treatment during pregnancy in women with SLE, is currently a promising agent for pre-eclampsia prevention. We aimed to examine associations between hydroxychloroquine use and pre-eclampsia and pre-term delivery in pregnant women with SLE. METHODS: In this nationwide population-based cohort study, we included all singleton pregnancies of women with prevalent SLE that lead to a delivery (livebirths and stillbirths) between Jan 1, 2007, and Dec 31, 2022, diagnosed in secondary or tertiary care centres in Sweden. Hydroxychloroquine exposure was defined as two or more dispensations from 3 months pre-pregnancy until the end of the first trimester. The primary outcomes were pre-eclampsia (diagnosed from 20+0 weeks of gestation to 6 weeks postpartum) and pre-term delivery (delivery before 37+0 weeks of gestation). Inverse probability of treatment weighting adjusted for measured confounders (eg, maternal smoking, BMI, reproductive characteristics, pre-gestational hypertension, glucocorticoid use) and modified Poisson models estimated risk ratios and 95% confidence intervals. We involved a person with lived experience of pregnancy with SLE in all aspects of the study. FINDINGS: Between Jan 1, 2007, and Dec 31, 2022, we included 959 singleton pregnancies from 685 women with prevalent SLE in Sweden. 404 (42%) of 959 pregnancies were nulliparous pregnancies (232 [57%] were unexposed and 172 [43%] were hydroxychloroquine-exposed) and 555 (58%) were parous pregnancies (333 [60%] were unexposed and 222 [40%] were hydroxychloroquine-exposed). The mean maternal age was 32 years (SD 4·7). Pre-eclampsia was recorded in 19 (11%) of 172 hydroxychloroquine-exposed pregnancies and 30 (13%) of 232 unexposed pregnancies in the nulliparous group and 12 (5%) of 222 hydroxychloroquine-exposed pregnancies and 20 (6%) of 333 unexposed pregnancies in the parous group. Pre-term delivery was recorded in 33 (19%) of 172 hydroxychloroquine-exposed pregnancies and 34 (15%) of 232 in unexposed pregnancies in the nulliparous group and 26 (12%) of 222 hydroxychloroquine-exposed pregnancies and 41 (12%) of 333 unexposed pregnancies in the parous group. The adjusted risk ratio for pre-eclampsia in SLE pregnancies with hydroxychloroquine exposure versus those without exposure was 0·49 (95% CI 0·31-0·79) overall, 0·59 (0·33-1·08) in the nulliparous group, and 0·44 (0·22-0·89) in the parous group. Associations between hydroxychloroquine and pre-term delivery were unclear in the overall (risk ratio 0·95 [95% CI 0·67-1·34]), nulliparous (1·10 [0·68-1·80]), and parous (0·75 [0·47-1·24]) groups. Stratification by antiphospholipid syndrome, renal diseases, and hypertension showed similar results. INTERPRETATION: In this large cohort of pregnant women with SLE, hydroxychloroquine exposure in early pregnancy was associated with a lower pre-eclampsia risk. However, the association with pre-term delivery was unclear. FUNDING: US National Institutes of Health and the Ingegerd Johansson Donation.

来源:Lancet Rheumatol,查看原文。版权归原作者所有。

引用

  1. Nguyen NV, Sandström A, Svenungsson E, et al. Exposure to hydroxychloroquine in early pregnancy and incidence of pre-eclampsia and pre-term delivery in patients with systemic lupus erythematosus in Sweden: a nationwide population-based cohort study. Lancet Rheumatol. 2025. PMID: 40516564. doi:10.1016/S2665-9913(25)00076-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。